We are live on
!
Find out more
EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
6 hedge funds and large institutions have $6.51M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
43% less capital invested
Capital invested by funds: $11.4M → $6.51M (-$4.89M)
54% less funds holding
Funds holding: 13 → 6 (-7)
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
6
Holders Change
-7
Holders Change %
-53.85%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
CS
Clear Street
New York
|
+$26.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.99K |